Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human KCNJ14 ELISA Kit (AC3360)
Cat.#: ASET-1949
Specifications
Description Human KCNJ14 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human KCNJ14 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 8.84 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2382 Mouse CCR5 ELISA Kit (AC3793) Quantitative inquiry ASET-2453 Human CLSTN1 ELISA Kit (AC3864) Quantitative inquiry ASET-2272 Mouse SNAP25 ELISA Kit (AC3683) Quantitative inquiry ASET-1538 Rat FOXO1A ELISA Kit (AC2949) Quantitative inquiry ASET-1863 Human Oxytocin Receptor ELISA Kit (AC3274) Quantitative inquiry ASET-2158 Human GDNF ELISA Kit (AC3569) Quantitative inquiry ASET-1630 Monkey Prealbumin ELISA Kit (AC3041) Quantitative inquiry ASET-1379 Human CD11b ELISA Kit (AC2790) Quantitative inquiry ASET-1643 Human GALC ELISA Kit (AC3054) Quantitative inquiry ASET-1184 Rat Somatostatin ELISA Kit (AC2595) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket